comparemela.com

Latest Breaking News On - Tc markets quoted - Page 3 : comparemela.com

Imugene Limited concludes A$95 million raise with heavily oversubscribed share purchase plan

The clinical-stage immune-oncology company will use the funds to support work across its three novel technology platforms and bolster its clinical.

Leslie-chong
Paul-hopper
லெஸ்லி-சோங்
பால்-ஹாப்பர்
Small-caps
Tc-markets-quoted
Otcqb-quoted
Harma-biotech
Imugene-limited
Asx-imu
Roactiveinvestors

Venture Minerals Ltd will send off first iron ore shipment in early September, shares up

The iron ore will be transported from Venture’s Riley mine in Tasmania to the Burnie port and eventually on to China.

China
Australia
Mount-lindsay
Northern-territory
Andrew-radonjic
Riley-iron-ore-mine
Prosperity-steel-united-singapore
Iron-ore
Kulin-project
Mount-lindsay-project
Small-caps

Adriatic Metals' says 'Vares silver project delivery and execution risks substantially reduced'

Adriatic Metals PLC (LSE:ADT1, ASX:ADT, FRA:3FNA, OTCQX:ADMLF) (LSE:ADT1)’s Paul Cronin joins Proactive London to discuss their Vares silver project in.

London
City-of
United-kingdom
Paul-cronin
Adriatic-metals
Proactive-london
லண்டன்
நகரம்-ஆஃப்
ஒன்றுபட்டது-கிஂக்டம்
பால்-குரோனின்
ப்ரோவாக்டிவ்-லண்டன்
Small-caps

Hochschild Mining PLC's adjusted earnings more than double in first half on higher gold and silver output

Production rose to 175,119 gold equivalent ounces from the pandemic-impacted 2020 figure of 126,835 ounces

Chile
Peru
Ignacio-bustamante
Hochschild-mining
Mid-caps
Tc-markets-quoted
Otcqx-quoted
Gold-silver
Hochschild-mining-plc
Lon-hoc
Roactiveinvestors
சிலி

Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. in collaboration to develop therapy for Stargardt disease

The agreement allows Aequus the option to acquire the North American commercial rights to REV-0100, reVision’s proprietary Stargardt disease program

New-york
United-states
American
Paul-fehlner
Doug-janzen
Aequus-pharmaceuticals
Drug-administration
Aequus-pharmaceuticals-inc
Vision-therapeutics
North-american
Priority-review-voucher
Rare-pediatric-disease-drug

vimarsana © 2020. All Rights Reserved.